Transmission of alpha-synuclein in Parkinson’s disease

被引：0
|
作者：
Virginia M-Y Lee
机构：
[1] University of Pennsylvania,
来源：
Molecular Neurodegeneration | / 8卷 / Suppl 1期
关键词：
Dementia; Lewy Body; Neuronal Excitability; Primary Neuron; Synaptic Protein;
D O I：
10.1186/1750-1326-8-S1-O25
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
    Parnetti, Lucilla
    Farotti, Lucia
    Eusebi, Paolo
    Chiasserini, Davide
    De Carlo, Claudia
    Giannandrea, David
    Salvadori, Nicola
    Lisetti, Viviana
    Tambasco, Nicola
    Rossi, Aroldo
    Majbour, Nour K.
    El-Agnaf, Omar
    Calabresi, Paolo
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [32] Alpha-Synuclein in the Gastrointestinal Tract as a Potential Biomarker for Early Detection of Parkinson's Disease
    Fricova, Dominika
    Harsanyiova, Jana
    Kralova Trancikova, Alzbeta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 21
  • [33] CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease
    Matsumoto, Lumine
    Takuma, Hiroshi
    Tamaoka, Akira
    Kurisaki, Hiroshi
    Date, Hidetoshi
    Tsuji, Shoji
    Iwata, Atsushi
    PLOS ONE, 2010, 5 (11):
  • [34] Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson's Disease Models
    Verma, Dinesh Kumar
    Seo, Bo Am
    Ghosh, Anurupa
    Ma, Shi-Xun
    Hernandez-Quijada, Karina
    Andersen, Julie K.
    Ko, Han Seok
    Kim, Yong-Hwan
    CELLS, 2021, 10 (07)
  • [35] Alpha-synuclein misfolding as fluid biomarker for Parkinson's disease measured with the iRS platform
    Schuler, Martin
    Gerwert, Grischa
    Mann, Marvin
    Woitzik, Nathalie
    Langenhoff, Lennart
    Hubert, Diana
    Duman, Deniz
    Hoeveler, Adrian
    Galkowski, Sandy
    Simon, Jonas
    Denz, Robin
    Weber, Sandrina
    Kwon, Eun-Hae
    Wanka, Robin
    Koetting, Carsten
    Gueldenhaupt, Joern
    Beyer, Leon
    Toenges, Lars
    Mollenhauer, Brit
    Gerwert, Klaus
    EMBO MOLECULAR MEDICINE, 2025,
  • [36] Elevated norepinephrine may interact with alpha-synuclein to promote Parkinson's disease and DLB
    Fitzgerald, Paul J.
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 3 - 4
  • [37] Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease
    Li, Xu-Ying
    Li, Wei
    Li, Xin
    Li, Xu-Ran
    Sun, Linjuan
    Yang, Weiwei
    Cai, Yanning
    Chen, Zhigang
    Wu, Jun
    Wang, Chaodong
    Yu, Shun
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [38] Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies
    Magalhaes, Pedro
    Lashuel, Hilal A.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [39] Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies
    Vekrellis, Kostas
    Stefanis, Leonidas
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) : 421 - 432
  • [40] Alpha-synuclein in peripheral tissues and body fluids as a biomarker for Parkinson's disease - a systematic review
    Malek, N.
    Swallow, D.
    Grosset, K. A.
    Anichtchik, O.
    Spillantini, M.
    Grosset, D. G.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (02): : 59 - 72
12345